Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 4 Quality Education -
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Corrigendum to: Maternal antibiotic administration during a critical developmental window has enduring neurobehavioural effects in offspring mice
O'Connor, R., Moloney, G. M., Füllling, C., O'Riordan, K., Fitzgerald, P., Schellekens, H., Dinan, T. G. & Cryan, J. F., 28 Mar 2026, In: Behavioural Brain Research. 502, 116041.Research output: Contribution to journal › Comment/Debate
Open Access -
Targeting the Microbiota Reverses C-Section-Induced Effects on Intestinal Permeability, Microbiota Composition, and Amygdala Gene Expression in the Mouse
Silva, A. P. V., Moloney, G. M., Sequeira, A. M., Liber, M., Bastiaanssen, T., Rea, K., Fitzgerald, P., Golubeva, A., Rodriguez-Aburto, M., Renes, I. B., Knol, J., Dinan, T. & Cryan, J. F., 2025, (Accepted/In press) In: Neurogastroenterology and Motility.Research output: Contribution to journal › Article › peer-review
Open Access -
A novel animal model for understanding secondary traumatic stress and visceral pain in male rats
Lannon, A. S., Brocka, M., Collins, J. M., Fitzgerald, P., O'Mahony, S. M., Cryan, J. F. & Moloney, R. D., Jul 2024, In: European Journal of Neuroscience. 60, 1, p. 3544-3556 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Beta 3-adrenoceptor agonism ameliorates early-life stress-induced visceral hypersensitivity in male rats
Collins, J. M., Hyland, N. P., Clarke, G., Fitzgerald, P., Julio-Pieper, M., Bulmer, D. C., Dinan, T. G., Cryan, J. F. & O'Mahony, S. M., Nov 2024, In: Journal of Neurochemistry. 168, 11, p. 3813-3826 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Beta 3‐adrenoceptor agonism ameliorates early‐life stress‐induced visceral hypersensitivity in male rats
Collins, J. M., Hyland, N. P., Clarke, G., Fitzgerald, P., Julio‐Pieper, M., Bulmer, D. C., Dinan, T. G., Cryan, J. F. & O'Mahony, S. M., Nov 2024, In: Journal of Neurochemistry.Research output: Contribution to journal › Article › peer-review
Activities
- 5 Invited talk
-
Treatment with a novel phospholipid-based drug formulation prevents behavioural deficits induced by proteasome inibition: implications for Parkinson's disease.
Crotty, S. (Speaker), Fitzgerald, P. (Speaker), Mandel, A. (Speaker), Bolton, A. E. (Speaker), Sullivan, A. (Speaker) & Nolan, Y. (Speaker)
14 Oct 2006 → 18 Oct 2006Activity: Talk or presentation › Invited talk
-
6-hydroxydopamine-induced p38 activation in rat nigral dopaminergic neurons is reduced by treatment with a novel phospholipid-based drug formulation.
Crotty, S. (Speaker), Fitzgerald, P. (Speaker), Harris, D. M. (Speaker), Fisher, A. (Speaker), Mandel, A. (Speaker), Bolton, A. E. (Speaker), Sullivan, A. (Speaker) & Nolan, Y. (Speaker)
14 Jun 2006Activity: Talk or presentation › Invited talk
-
Neuroprotective evidence of a novel phospholipid-based drug formulation in a rat model of parkinson¿s disease.
Crotty, S. (Speaker), Fitzgerald, P. (Speaker), Harris, D. M. (Speaker), Fisher, A. (Speaker), Mandel, A. (Speaker), Bolton, A. E. (Speaker), Sullivan, A. (Speaker) & Nolan, Y. (Speaker)
2006Activity: Talk or presentation › Invited talk
-
Treatment with a novel phospholipid-based drug formulation inhibits 6-hydroxydopamine-induced p38 activation in rat substantia nigra.
Fitzgerald, P. (Speaker), Harris, D. M. (Speaker), Crotty, S. (Speaker), Harkin, A. J. (Speaker), Mandel, A. (Speaker), Bolton, A. E. (Speaker), Sullivan, A. (Speaker) & Nolan, Y. (Speaker)
12 Nov 2005 → 16 Nov 2005Activity: Talk or presentation › Invited talk
-
6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation.
Fitzgerald, P. (Speaker), Harris, D. M. (Speaker), Crotty, S. (Speaker), Fisher, A. (Speaker), Bolton, A. E. (Speaker), Sullivan, A. (Speaker) & Nolan, Y. (Speaker)
2005Activity: Talk or presentation › Invited talk
Press/Media
-
Study Results from University College Cork in the Area of Hypersensitivity Reported (Beta 3-adrenoceptor Agonism Ameliorates Early-life Stress-induced Visceral Hypersensitivity In Male Rats)
Clarke, G., Fitzgerald, P., Cryan, J. F., O'Mahony, S., Hyland, N. & Collins, M.
28/11/24
1 item of Media coverage
Press/Media
-
Monday’s best TV: Captivating RTÉ documentary tells the story of ‘The Cable that Changed the World’
12/08/24
1 item of Media coverage
Press/Media
-
‘The Cable that Changed the World’ review: A captivating documentary of the cable from Kerry to Canada that few believed could be done
12/08/24
1 item of Media coverage
Press/Media
-
The Cable That Changed the World: A bit like a double history lecture on a hot day
12/08/24
1 item of Media coverage
Press/Media